These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27321817)

  • 1. OncoScape: Exploring the cancer aberration landscape by genomic data fusion.
    Schlicker A; Michaut M; Rahman R; Wessels LF
    Sci Rep; 2016 Jun; 6():28103. PubMed ID: 27321817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide identification of significant aberrations in cancer genome.
    Yuan X; Yu G; Hou X; Shih IeM; Clarke R; Zhang J; Hoffman EP; Wang RR; Zhang Z; Wang Y
    BMC Genomics; 2012 Jul; 13():342. PubMed ID: 22839576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
    Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
    Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCG: an integrative resource of cancer protein-coding genes and long noncoding RNAs.
    Liu M; Yang YT; Xu G; Tan C; Lu ZJ
    Discov Med; 2016 Dec; 22(123):351-359. PubMed ID: 28147217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genomics to explore cancer cell vulnerabilities.
    Kahle KT; Kozono D; Ng K; Hsieh G; Zinn PO; Nitta M; Chen CC
    Neurosurg Focus; 2010 Jan; 28(1):E5. PubMed ID: 20043720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
    Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
    Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Towards an inventory of oncogenic mutations in cancer].
    Theillet C
    Bull Cancer; 2010 Nov; 97(11):1223-9. PubMed ID: 21059490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
    Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A
    Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene polymorphisms].
    Robert J
    Bull Cancer; 2010 Nov; 97(11):1253-64. PubMed ID: 21115419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
    Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
    Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.